Spartan’s rapid, portable test allows real-time, near patient determination of the patient’s genotype, aiding in determining the appropriate antiplatelet treatment.
(PRWeb December 05, 2019)
Read the full story at https://www.prweb.com/releases/spartan_bioscience_and_angiocare_partner_to_bring_the_worlds_first_rapid_precision_medicine_dna_test_to_cardiac_stent_patients_in_europe/prweb16763606.htm